SCHEMBL5656109

SCHEMBL5656109

COC(CN(C)Cc1ccccc1)OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 1/20 0.48
PRMT6 Q96LA8 1/20 0.48
PRMT8 Q9NR22 1/20 0.48
TSHR P16473 4/20 0.48
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 2/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47
LMNA P02545 2/20 0.47
USP2 O75604 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAOA P21397 1/20 0.47
MAOB P27338 1/20 0.47
PYCR1 P32322 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.46
BLM P54132 1/20 0.46
DNM1 Q05193 1/20 0.45
AOC3 Q16853 1/20 0.45
POLB P06746 1/20 0.45
SIGMAR1 Q99720 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7338804 0.82 TSHR (0.46) TSHRALDH1A1KDM4EGAAMAPT
SCHEMBL13452933 0.81 CARM1 (0.46) CARM1PRMT6PRMT8TSHRALDH1A1
SCHEMBL9200826 0.81 CARM1 (0.46) CARM1PRMT6PRMT8TSHRALDH1A1
SCHEMBL9016852 0.78 TSHR (0.54) TSHRALDH1A1KDM4EMAOBPOLB
SCHEMBL172668 0.78 TSHR (0.54) CARM1PRMT6PRMT8TSHRALDH1A1
Dibemethine SCHEMBL10542007 0.76 ALDH1A1 (0.70) CARM1PRMT6PRMT8TSHRALDH1A1
Dibemethine SCHEMBL276863 0.76 ALDH1A1 (0.70) CARM1PRMT6PRMT8TSHRALDH1A1
SCHEMBL9700093 0.76 DNM1 (0.55) CARM1PRMT6PRMT8TSHRALDH1A1
SCHEMBL7337030 0.76 PIK3CD (0.35) AOC3
SCHEMBL3440739 0.75 PYCR1 (0.56) ALDH1A1MAPTLMNAPYCR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7109233-B2 Protease inhibitors SMITHKLINE BEECHAM CORPORATION (US) 2006-09-19 US disclosed
EP-1532115-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2006-01-11 EP disclosed
US-20050234038-A1 Protease inhibitors SMITHKLINE BEECHAM CORPORATION 2005-10-20 US disclosed
EP-1532115-A2 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2005-05-25 EP disclosed
WO-2003104257-A2 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-12-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234038-A1 Protease inhibitors SPINT2, CTRL, PRSS1 CARM1 3820/4885PRMT6 1141/4885PRMT8 2236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.